Wait for Pfizer's COVID vaccine could be long: Pfizer scientist

New Delhi: Pfizer vaccine for Coronavirus claimed that it is 90% effective to fight against the virus. But it would be quite difficult to be delivered in India as it is expensive says a CMC Vellore professor.

Medical scientist, Dr Gagandeep Kang said that Pfizer's coronavirus vaccine is an mRNA vaccine while it's not decided how much it will cost. Dr. Gagandeep Kang said, "For India, RNA vaccines are going to be very expensive."

Even though the Indian government is open to dialogue with the vaccine manufacturer, Pfizer but it's would be a challenge to deliver in every corners of the country.

The vaccine will be difficult to deliver because this vaccine needs to be kept at minus 70 degrees Celsius (-94 F) or below.

Amesh Adalja said, "This will be a challenge in all settings because hospitals even in big cities do not have storage facilities for a vaccine at that ultra-low temperature,"

Congress leader Rahul Gandhi tweeted, "Even though Pfizer has created a promising vaccine, the logistics for making it available to every Indian need to be worked out. GOI has to define a vaccine distribution strategy and how it will reach every Indian."

Also read: India remembers Maulana Abul Kalam Azad on National Education Day

Also watch: Assam Agri Minister Atul Bora Not a Factor: AJP